CD11b在上皮性卵巢癌中的新表达:潜在治疗靶点
本研究检测了CD11b在上皮性卵巢癌细胞系与组织中的表达,并用单克隆抗体靶向CD11b,在敏感及化疗耐药细胞系、正常细胞及裸鼠移植瘤模型中评估细胞毒性与协同作用;发现CD11b在多种上皮性卵巢癌细胞系和组织中意外表达而正常组织不表达,抗体对敏感及耐药细胞均有细胞毒性且不影响正常细胞,与顺铂或多西他赛联用呈显著协同,裸鼠模型证实抗肿瘤效应。
要点
- CD11b在多种上皮性卵巢癌细胞系和组织中意外表达,正常组织不表达。
- CD11b单克隆抗体对敏感及化疗耐药上皮性卵巢癌细胞系有细胞毒性,对正常细胞无影响。
- CD11b抗体与顺铂或多西他赛联用在敏感及耐药细胞中呈显著协同,裸鼠移植瘤模型证实抗肿瘤效应。
核心结论
- CD11b是选择性诱导卵巢癌细胞细胞毒性的新靶点。
研究设计与样本
- 研究采用上皮性卵巢癌细胞系与组织检测CD11b表达,并用单克隆抗体在细胞与裸鼠移植瘤模型中评估靶向效应。
主要发现
- CD11b在多种上皮性卵巢癌细胞系和组织中意外表达,正常组织不表达。
- CD11b单克隆抗体在敏感及化疗耐药上皮性卵巢癌细胞系中产生细胞毒性,对正常细胞无影响。
- CD11b抗体与顺铂或多西他赛联用在敏感及耐药上皮性卵巢癌细胞中呈显著协同。
- CD11b抗体的抗肿瘤效应在卵巢癌裸鼠移植瘤模型中得到证实。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine the expression, and effect of targeting CD11b with a monoclonal antibody in ovarian cancer cells. METHODS: CD11b expression was determined in epithelial ovarian cancer (EOC) cell lines and tissues by immunofluorescence and flow cytometry. Cytotoxicity of the CD11b antibody and synergism with chemothearapeutic drugs were determined by the MTT Cell Proliferation Assay in human macrophages, normal ovarian epithelial cells, and in both sensitive and chemoresistant EOC cell lines. Cell migration was assessed with a scratch assay and in vivo effects of the CD11b antibody was assessed with a nude mouse ovarian cancer xenograft model. Data was analyzed with either t-tests or one-way ANOVA. RESULTS: CD11b was unexpectedly expressed in several EOC lines and tissues, but not normal tissues. Targeting CD11b with its monoclonal antibody resulted in intriguing cytotoxic effects in sensitive and chemoresistant EOC lines, while surprisingly not affecting normal cells. More importantly, the cytotoxicity of the CD11b antibody when combined with chemotherapeutic drugs (cisplatin or docetaxel) was significantly synergistic, in both sensitive and chemoresistant EOC cells. The anti-tumorigenic effect of the CD11b antibody was confirmed in an ovarian cancer nude mouse xenograft model. CONCLUSION: Here we identify CD11b as a novel target, which selectively induces cytotoxicity in ovarian cancer cells.
引用
- Saed GM, Fletcher NM, Diamond MP, et al. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target. Gynecol Oncol. 2018. PMID: 29329880. doi:10.1016/j.ygyno.2017.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。